PATH’s Center for Vaccine Innovation and Access

Vaccines for the people who need them most

PATH’s Center for Vaccine Innovation and Access (CVIA) brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally available to women, children, and communities, particularly in low resource settings. CVIA’s current portfolio encompasses more than two dozen vaccine projects either in development or already in use to protect against 17 different diseases, including enteric and diarrheal diseases, malaria, meningitis, pneumonia, and polio. Find out more »

Indian-made rotavirus vaccine achieves WHO prequalification

Photo: PATH/Gabe Bienczycki

PATH applauds Indian vaccine manufacturer Bharat Biotech for receiving prequalification from the World Health Organization (WHO) for their oral rotavirus vaccine, ROTAVAC®. Rotavirus is the most common cause of severe diarrheal disease in children worldwide, and vaccination is the best way to prevent severe rotavirus illness. Read the announcement »


in the news: Typhoid vaccine made in India receives WHO prequalification »

in the news: WHO prequalifies Chinese-made polio vaccine »

blog: PATH exploring pathway to universal flu vaccine »

blog: Finnish scientists are studying a ETEC vaccine candidate in Benin. Learn more »

resource: PATH’s Vaccine Resource library has a new location »

Sign up for our e-newsletters

cvia-home-mtn-enewsMoving the Needle provides quarterly updates on vaccine development. Subscribe »

Immunization Matters provides quarterly updates on vaccine uptake and access. Subscribe »

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. Learn more »

Banner photos, clockwise from left: PATH/Aaron Joel Santos; PATH/Will Boase; PATH/Gabe Bienczycki.